This continuing education session, “Weighing the Options: Updates and Clinical Considerations in Weight Management,” provides a timely review of the rapidly evolving landscape of weight management pharmacotherapy. Participants will explore newly approved agents and formulations, including oral semaglutide, updated cardiovascular and liver indications, and emerging access pathways. The program highlights comparative efficacy data, safety considerations, and patient-centered selection strategies while addressing cost, insurance coverage changes, and Medicare updates that directly impact access to care. Emphasis is placed on practical application, prior authorization documentation, motivational interviewing, and reducing obesity bias to support sustainable, equitable obesity management.